MACOM Reports Fiscal Third Quarter 2020 Financial Results

Investors are cautioned against placing undue reliance on these non-GAAP financial measures and are urged to review and consider carefully the adjustments made by management to the most directly comparable GAAP financial measures to arrive at these non-GAAP financial measures. Non-GAAP financial measures may have limited value as analytical tools because they may exclude certain expenses that some investors consider important in evaluating our operating performance or ongoing business performance. Further, non-GAAP financial measures may have limited value for purposes of drawing comparisons between companies because different companies may calculate similarly titled non-GAAP financial measures in different ways because non-GAAP measures are not based on any comprehensive set of accounting rules or principles.

Additional information and managements assessment regarding why certain items are excluded from our non-GAAP measures are summarized below:

Amortization Expense - is related to acquired intangible assets which are based upon valuation methodologies, and are generally amortized over the expected life of the intangible asset at the time of acquisition, which may result in amortization amounts that vary over time. This is a non-cash expense and is not considered by management in making operating decisions.

Share-Based and Non-cash Compensation Expense - includes share-based compensation expense for awards that are equity and liability classified on our balance sheet. Share-based compensation expense is partially outside of our control due to factors such as stock price volatility and interest rates, which may be unrelated to our operating performance during the period in which the expense is incurred. It is an expense based upon valuation methodologies and assumptions that vary over time, and the amount of the expense can vary significantly between companies due to factors that can be outside of their control. Share-based and non-cash compensation expense amounts are not considered by management in making operating decisions.

Impairment-Related Charges - includes amounts associated with the impairment of intangible assets and property and equipment primarily associated with our decision in the third fiscal quarter of 2019 to cease design and development of optical modules and subsystems for Data Center applications, close certain product development facilities and reduce certain development activities for one of our product lines. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.

Restructuring Charges - includes amounts primarily associated with approved plans to reduce staffing and manufacturing, research and development and administrative footprints, including amounts associated with the 2019 restructuring and other restructuring plans. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.

Warrant Liability Expenses/Gains - are associated with mark-to-market fair value adjustments which are largely based on the value of our common stock, which may vary from period to period due to factors such as stock price volatility. We believe these amounts are not correlated to future business operations and including such charges does not reflect our ongoing operations.

Non-cash Interest, Net - includes amounts associated with the amortization of certain fees associated with the establishment or amendment of our credit agreement and term loans that are being amortized over the life of the agreement. We believe these amounts are non-cash in nature and not correlated to future business operations and including such charges does not reflect our ongoing operations.

Litigation Costs - includes gains, losses and expenses related to the resolution of other-than-ordinary-course threatened and actually filed lawsuits and other-than-ordinary-course contractual disputes and legal matters. We exclude these gains and losses because they are not considered by management in making operating decisions. We believe such gains, losses and expenses do not necessarily reflect the performance of our ongoing operations for the period in which such charges are recognized and the amount of such gains or losses and expenses can vary significantly between companies and make comparisons less reliable.

Acquisition, Integration and Restructuring Related Costs - includes such items as professional fees incurred in connection with pre-acquisition and integration specific activities, contingent consideration adjustments, severance and other amounts accrued or paid to terminated employees of acquired businesses, costs including salaries incurred which are not expected to have a continuing contribution to operations. We believe the exclusion of these items is useful in providing management a basis to evaluate ongoing operating activities and strategic decision making.

Equity Investment and Sale of Business Losses and Other - primarily includes losses associated with a non-marketable equity investment we have in a private business as well as other gains and losses associated with historical acquisitions and divestitures. The investment losses are non-cash in nature and we believe these items are not correlated to future business operations and including such amounts does not reflect our ongoing operations.

Tax Effect of Non-GAAP Adjustments - adjustments to arrive at an estimate of our adjusted non-GAAP income tax rate associated with our adjusted non-GAAP income over a period of time. We determine our adjusted non-GAAP income tax rate by using applicable rates in taxing jurisdictions and assessing certain factors including our historical and forecast earnings by jurisdiction, discrete items, cash taxes paid in relation to our adjusted non-GAAP net income before income taxes and our ability to realize tax assets. We generally assess this adjusted non-GAAP income tax rate quarterly and have utilized 8% for our fiscal years 2019 and 2020. Our historical effective income tax rate under GAAP has varied significantly from our adjusted non-GAAP income tax rate. Items that have historically resulted in significant difference between our effective income tax rate under GAAP and our adjusted non-GAAP income tax rate include changes in fair values of the common stock warrant liability, which are excluded from our adjusted net income and are neither deductible nor taxable for tax purposes, losses or gains associated with our equity method investment in a private business, income taxed in foreign jurisdictions at generally lower tax rates, intangible impairments, research and development tax credits and merger expenses. We believe it is beneficial for our management to review our adjusted non-GAAP income tax rate on a consistent basis over periods of time. Items such as those noted above may have a significant impact on our GAAP income tax expense and associated effective tax rate over time. Our adjusted non-GAAP income tax rate is an estimate, and may differ from our effective income tax rate determined under GAAP.

Adjusted EBITDA - is a calculation that adds depreciation expense to our adjusted income from operations. Adjusted EBITDA is a measure that management reviews and utilizes for operational analysis purposes. We believe competitors and others in the financial industry utilize this non-GAAP measure for analysis purposes.

Free Cash Flow - is a calculation that starts with cash flow from operating activities, reduces this amount by our capital expenditures in the applicable period. Free Cash Flow is a measure that management reviews and utilizes for cash flow analysis purposes. We believe competitors and others in the financial industry utilize this non-GAAP measure for analyzing a company’s cash flow.

Incremental Shares - is the number of potential shares of common stock issuable upon the exercise of stock options, restricted stock, restricted stock units and warrants which were not included in the calculation of our GAAP diluted shares. We believe competitors and others in the financial industry utilize this non-GAAP measure for analysis purposes.

 

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited and in thousands, except per share data)

 

 

Three Months Ended

 

Nine Months Ended

 

July 3,

2020

 

April 3,

2020

 

June 28,

2019

 

July 3,

2020

 

June 28,

2019

 

 

 

 

 

Revenue

$

137,267

 

 

$

126,424

 

 

$

108,306

 

 

$

382,788

 

 

$

387,460

 

Cost of revenue

66,391

 

 

63,054

 

 

74,478

 

 

190,338

 

 

219,678

 

Gross profit

70,876

 

 

63,370

 

 

33,828

 

 

192,450

 

 

167,782

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

34,948

 

 

35,830

 

 

42,708

 

 

105,936

 

 

128,593

 

Selling, general and administrative

29,982

 

 

31,994

 

 

41,920

 

 

94,317

 

 

126,437

 

Impairment charges

 

 

 

 

264,086

 

 

 

 

264,086

 

Restructuring (benefit) charges

(554)

 

 

815

 

 

8,887

 

 

1,494

 

 

17,047

 

Total operating expenses

64,376

 

 

68,639

 

 

357,601

 

 

201,747

 

 

536,163

 

Income (loss) from operations

6,500

 

 

(5,269)

 

 

(323,773)

 

 

(9,297)

 

 

(368,381)

 

Other (expense) income:

 

 

 

 

 

 

 

 

 

Warrant liability (expense) gain

(19,511)

 

 

8,647

 

 

1,927

 

 

(14,951)

 

 

5,788

 

Interest expense, net

(5,849)

 

 

(7,672)

 

 

(8,967)

 

 

(22,142)

 

 

(27,142)

 

Other (expense) income, net

(4,372)

 

 

(4,352)

 

 

4,777

 

 

(12,464)

 

 

(4,233)

 

Total other expense

(29,732)

 

 

(3,377)

 

 

(2,263)

 

 

(49,557)

 

 

(25,587)

 

Loss before income taxes

(23,232)

 

 

(8,646)

 

 

(326,036)

 

 

(58,854)

 

 

(393,968)

 

Income tax expense (benefit)

1,750

 

 

1,580

 

 

(1,322)

 

 

4,716

 

 

346

 

Net loss

$

(24,982)

 

 

$

(10,226)

 

 

$

(324,714)

 

 

$

(63,570)

 

 

$

(394,314)

 

 

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

 

Loss per share - Basic

$

(0.37)

 

 

$

(0.15)

 

 

$

(4.93)

 

 

$

(0.96)

 

 

$

(6.01)

 

Loss per share - Diluted

$

(0.37)

 

 

$

(0.28)

 

 

$

(4.95)

 

 

$

(0.96)

 

 

$

(6.09)

 

Weighted average common shares

 

 

 

 

 

 

 

 

 

Shares - Basic

66,796

 

 

66,522

 

 

65,858

 

 

66,512

 

 

65,555

 

Shares - Diluted

66,796

 

 

67,085

 

 

65,945

 

 

66,512

 

 

65,722

 

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited and in thousands)

 

 

 

July 3,

2020

 

September 27,
2019

 

 

 

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

131,870

 

 

$

75,519

 

Short term investments

 

133,248

 

 

101,226

 

Accounts receivable, net

 

60,504

 

 

69,790

 

Inventories

 

95,576

 

 

107,880

 

Income tax receivable

 

18,904

 

 

16,661

 

Prepaids and other current assets

 

10,166

 

 

27,506

 

Total current assets

 

450,268

 

 

398,582

 

Property and equipment, net

 

122,000

 

 

132,647

 

Goodwill and intangible assets, net

 

458,096

 

 

495,955

 

Deferred income taxes

 

41,648

 

 

43,812

 

Other investments

 

9,975

 

 

23,613

 

Other long-term assets

 

39,140

 

 

10,965

 

TOTAL ASSETS

 

$

1,121,127

 

 

$

1,105,574

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Current portion of finance lease obligations and other

 

$

1,506

 

 

$

1,084

 

Current portion of long-term debt

 

6,885

 

 

6,885

 

Accounts payable

 

25,599

 

 

24,822

 

Accrued liabilities

 

53,539

 

 

39,908

 

Deferred revenue

 

7,488

 

 

2,137

 

Total current liabilities

 

95,017

 

 

74,836

 

Finance lease obligations and other, less current portion

 

29,351

 

 

29,506

 

Long-term debt obligations, less current portion

 

652,947

 

 

655,272

 

Common stock warrant liability

 

27,315

 

 

12,364

 

Other long-term liabilities

 

43,193

 

 

19,700

 

Total liabilities

 

847,823

 

 

791,678

 

Stockholders’ equity

 

273,304

 

 

313,896

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

1,121,127

 

 

$

1,105,574

 

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited and in thousands)

 

 

 

Nine Months Ended

 

 

July 3,

2020

 

June 28,

2019

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

Net loss

 

$

(63,570)

 

 

$

(394,314)

 

Depreciation and amortization

 

59,751

 

 

84,612

 

Share based compensation

 

26,921

 

 

20,163

 

Warrant liability expense (gain)

 

14,951

 

 

(5,788)

 

Deferred income taxes

 

3,581

 

 

59

 

Loss on minority equity investment

 

13,637

 

 

3,937

 

Impairment and restructuring related charges

 

 

 

272,873

 

Other adjustments to reconcile loss to net operating cash

 

4,239

 

 

3,441

 

Accounts receivable

 

9,286

 

 

29,291

 

Inventories

 

12,304

 

 

12,298

 

Change in other operating assets and liabilities

 

15,894

 

 

1,705

 

Net cash provided by operating activities

 

96,994

 

 

28,277

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

Purchases of property and equipment

 

(12,658)

 

 

(31,905)

 

Sales, purchases and maturities of investments

 

(30,681)

 

 

(780)

 

Acquisition of businesses, net

 

 

 

(375)

 

Proceeds from divested business

 

11,003

 

 

 

Proceeds from sale of assets

 

366

 

 

 

Net cash used in investing activities

 

(31,970)

 

 

(33,060)

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

Payments of long-term debt

 

(5,163)

 

 

(5,163)

 

Payments on finance leases and other

 

(1,307)

 

 

(809)

 

Proceeds from stock option exercises and employee stock purchases

 

4,565

 

 

5,631

 

Repurchase of common stock - tax withholdings on equity awards

 

(6,557)

 

 

(3,872)

 

Other adjustments

 

 

 

(579)

 

Net used in financing activities

 

(8,462)

 

 

(4,792)

 

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

 

(211)

 

 

164

 

NET CHANGE IN CASH AND CASH EQUIVALENTS

 

56,351

 

 

(9,411)

 

CASH AND CASH EQUIVALENTS — Beginning of period

 

75,519

 

 

94,676

 

CASH AND CASH EQUIVALENTS — End of period

 

$

131,870

 

 

$

85,265

 

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.

RECONCILIATIONS OF GAAP TO NON-GAAP RESULTS

(unaudited and in thousands, except per share data)

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Gross profit - GAAP

$

70,876

 

51.6

 

$

63,370

 

50.1

 

$

33,828

 

31.2

 

$

192,450

 

50.3

 

$

167,782

 

43.3

 

Amortization expense

4,347

 

3.2

 

4,347

 

3.4

 

8,149

 

7.5

 

13,115

 

3.4

 

24,074

 

6.2

 

Share-based and non-cash compensation expense

1,024

 

0.7

 

1,153

 

0.9

 

662

 

0.6

 

3,229

 

0.8

 

2,137

 

0.6

 

Impairment related charges

 

 

 

 

 

 

 

 

(991)

 

(0.3)

 

Acquisition, integration and restructuring related costs

 

 

 

 

 

 

 

 

547

 

0.1

 

Adjusted gross profit (Non-GAAP)

$

76,247

 

55.5

 

$

68,870

 

54.5

 

$

42,639

 

39.4

 

$

208,794

 

54.5

 

$

193,549

 

50.0

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Operating expenses - GAAP

$

64,376

 

46.9

 

$

68,639

 

54.3

 

$

357,601

 

330.2

 

$

201,747

 

52.7

 

$

536,163

 

138.4

 

Amortization expense

(8,071)

 

(5.9)

 

(8,071)

 

(6.4)

 

(13,713)

 

(12.7)

 

(24,798)

 

(6.5)

 

(38,115)

 

(9.8)

 

Share-based and non-cash compensation expense

(9,908)

 

(7.2)

 

(10,431)

 

(8.3)

 

(2,383)

 

(2.2)

 

(28,456)

 

(7.4)

 

(19,191)

 

(5.0)

 

Impairment and restructuring benefit (charges)

554

 

0.4

 

(815)

 

(0.6)

 

(272,973)

 

(252.0)

 

(1,494)

 

(0.4)

 

(281,133)

 

(72.6)

 

Litigation costs

 

 

 

 

 

 

 

 

(167)

 

 

Acquisition, integration and restructuring related costs

(22)

 

 

(22)

 

 

(3,612)

 

(3.3)

 

(66)

 

 

(6,433)

 

(1.7)

 

Adjusted operating expenses (Non-GAAP)

$

46,929

 

34.2

 

$

49,300

 

39.0

 

$

64,920

 

59.9

 

$

146,933

 

38.4

 

$

191,124

 

49.3

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Income (loss) from operations - GAAP

$

6,500

 

4.7

 

$

(5,269)

 

(4.2)

 

$

(323,773)

 

(298.9)

 

$

(9,297)

 

(2.4)

 

$

(368,381)

 

(95.1)

 

Amortization expense

12,417

 

9.0

 

12,418

 

9.8

 

21,862

 

20.2

 

37,911

 

9.9

 

62,189

 

16.1

 

Share-based and non-cash compensation expense

10,933

 

8.0

 

11,585

 

9.2

 

3,045

 

2.8

 

31,685

 

8.3

 

21,298

 

5.5

 

Impairment and restructuring (benefit) charges

(554)

 

(0.4)

 

815

 

0.6

 

272,973

 

252.0

 

1,494

 

0.4

 

280,142

 

72.3

 

Litigation costs

 

 

 

 

 

 

 

 

167

 

 

Acquisition, integration and restructuring related costs

22

 

 

22

 

 

3,612

 

3.3

 

66

 

 

7,011

 

1.8

 

Adjusted income (loss) from operations (Non-GAAP)

$

29,318

 

21.4

 

$

19,571

 

15.5

 

$

(22,281)

 

(20.6)

 

$

61,859

 

16.2

 

$

2,426

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation expense

7,092

 

5.2

 

7,319

 

5.8

 

7,272

 

6.7

 

21,840

 

5.7

 

22,423

 

5.8

 

Adjusted EBITDA (Non-GAAP)

$

36,410

 

26.5

 

$

26,890

 

21.3

 

$

(15,009)

 

(13.9)

 

$

83,699

 

21.9

 

$

24,849

 

6.4

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Net loss - GAAP

$

(24,982)

 

(18.2)

 

$

(10,226)

 

(8.1)

 

$

(324,714)

 

(299.8)

 

$

(63,570)

 

(16.6)

 

$

(394,314)

 

(101.8)

 

Amortization expense

12,418

 

9.0

 

12,418

 

9.8

 

21,862

 

20.2

 

37,912

 

9.9

 

62,189

 

16.1

 

Share-based and non-cash compensation expense

10,933

 

8.0

 

11,585

 

9.2

 

3,075

 

2.8

 

31,685

 

8.3

 

21,328

 

5.5

 

Impairment and restructuring (benefit) charges

(554)

 

(0.4)

 

815

 

0.6

 

272,973

 

252.0

 

1,494

 

0.4

 

280,142

 

72.3

 

Warrant liability expense (gain)

19,511

 

14.2

 

(8,647)

 

(6.8)

 

(1,927)

 

(1.8)

 

14,951

 

3.9

 

(5,788)

 

(1.5)

 

Non-cash interest, net

1,015

 

0.7

 

1,015

 

0.8

 

1,015

 

0.9

 

3,046

 

0.8

 

3,046

 

0.8

 

Litigation costs

 

 

 

 

 

 

 

 

167

 

 

Acquisition, integration and restructuring related costs

22

 

 

22

 

 

3,582

 

3.3

 

66

 

 

6,980

 

1.8

 

Equity investment, sale of business losses and other

4,571

 

3.3

 

4,354

 

3.4

 

(4,705)

 

(4.3)

 

12,675

 

3.3

 

4,155

 

1.1

 

Tax effect of non-GAAP adjustments

(224)

 

(0.2)

 

546

 

0.4

 

1,091

 

1.0

 

1,278

 

0.3

 

2,086

 

0.5

 

Adjusted net income (loss) (Non-GAAP)

$

22,710

 

16.5

 

$

11,882

 

9.4

 

$

(27,748)

 

(25.6)

 

$

39,537

 

10.3

 

$

(20,009)

 

(5.2)

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Net Income
(Loss)

Income (loss)
per diluted
share

Net Income
(Loss)

Income (loss)
per diluted
share

Net Income
(Loss)

Income (loss)
per diluted
share

Net Income
(Loss)

Income (loss)
per diluted
share

Net Income
(Loss)

Income (loss)
per diluted
share

Net loss - GAAP

$

(24,982)

 

 

$

(10,226)

 

 

$

(324,714)

 

 

$

(63,570)

 

 

$

(394,314)

 

 

Warrant liability expense (gain)

19,511

 

 

(8,647)

 

 

(1,927)

 

 

14,951

 

 

(5,788)

 

 

Net loss - diluted

$

(5,471)

 

$

(0.37)

 

$

(18,873)

 

$

(0.28)

 

$

(326,641)

 

$

(4.95)

 

$

(48,619)

 

$

(0.96)

 

$

(400,102)

 

$

(6.09)

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (loss) (Non-GAAP)

$

22,710

 

$

0.33

 

$

11,882

 

$

0.17

 

$

(27,748)

 

$

(0.42)

 

$

39,537

 

$

0.58

 

$

(20,009)

 

$

(0.30)

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Shares

 

Shares

 

Shares

 

Shares

 

Shares

 

Diluted shares - GAAP

66,796

 

 

67,085

 

 

65,945

 

 

66,512

 

 

65,722

 

 

Incremental shares

1,767

 

 

1,010

 

 

80

 

 

1,544

 

 

130

 

 

Adjusted diluted shares (Non-GAAP)

68,563

 

 

68,095

 

 

66,025

 

 

68,056

 

 

65,852

 

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Interest expense, net - GAAP

$

5,849

 

4.3

 

$

7,672

 

6.1

 

$

8,967

 

8.3

 

$

22,142

 

5.8

 

$

27,142

 

7.0

 

Non-cash interest expense

(1,015)

 

(0.7)

 

(1,015)

 

(0.8)

 

(1,015)

 

(0.9)

 

(3,046)

 

(0.8)

 

(3,046)

 

(0.8)

 

Adjusted interest expense (Non-GAAP)

$

4,834

 

3.5

 

$

6,657

 

5.3

 

$

7,952

 

7.3

 

$

19,096

 

5.0

 

$

24,096

 

6.2

 

 

Three Months Ended

Nine Months Ended

 

July 3, 2020

April 3, 2020

June 28, 2019

July 3, 2020

June 28, 2019

 

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Cash flow from operations

$

34,056

 

24.8

 

$

25,280

 

20.0

 

$

1,439

 

1.3

 

$

96,994

 

25.3

 

$

28,277

 

7.3

 

Capital expenditures

(3,622)

 

(2.6)

 

(4,788)

 

(3.8)

 

(9,305)

 

(8.6)

 

(12,658)

 

(3.3)

 

(31,905)

 

(8.2)

 

Free cash flow (Non-GAAP)

$

30,434

 

22.2

 

$

20,492

 

16.2

 

$

(7,866)

 

(7.3)

 

$

84,336

 

22.0

 

$

(3,628)

 

(0.9)

 

Free cash flow as a percentage of Adjusted net income

134

%

 

172

%

 

(28)

%

 

213

%

 

(18)

%

 





© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise